Successful transcatheter perforation of the atretic pulmonary valve membrane in a newborn using the new Coe radiofrequency end hole catheter

The new 2 French Coe radiofrequency (RF) end hole catheter was first used to successfully perforate the atretic pulmonary valve membrane using an antegrade approach in a newborn with intact ventricular septum (IVS). Nine watts of energy for 8 sec was required with simultaneous delivery of a 0.014 in...

Full description

Saved in:
Bibliographic Details
Published in:Catheterization and cardiovascular diagnosis 1998-10, Vol.45 (2), p.162-166
Main Authors: Cheatham, John P., Coe, James Y., Kugler, John D., Fletcher, Scott E., Tower, Allen J.
Format: Article
Language:English
Subjects:
Biological and medical sciences
Cardiac Catheterization - instrumentation
Catheter Ablation - instrumentation
Catheterization
Diseases of the cardiovascular system
Equipment Design
Female
Humans
Infant, Newborn
Medical sciences
pulmonary atresia
Pulmonary Atresia - therapy
radiofrequency catheter
Radiotherapy. Instrumental treatment. Physiotherapy. Reeducation. Rehabilitation, orthophony, crenotherapy. Diet therapy and various other treatments (general aspects)
transcatheter perforation
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The new 2 French Coe radiofrequency (RF) end hole catheter was first used to successfully perforate the atretic pulmonary valve membrane using an antegrade approach in a newborn with intact ventricular septum (IVS). Nine watts of energy for 8 sec was required with simultaneous delivery of a 0.014 in. coronary guidewire coaxially through the end hole RF catheter for balloon valvuloplasty. This new ringed‐tip end hole RF catheter offers considerable advantages to the pediatric interventionalist in the transcatheter therapy in neonates with pulmonary atresia (PA) and IVS. Cathet. Cardiovasc. Diagn. 45:162–166, 1998. © 1998 Wiley‐Liss, Inc.
ISSN:0098-6569
1097-0304
DOI:10.1002/(SICI)1097-0304(199810)45:2<162::AID-CCD13>3.0.CO;2-N